You need to login...
If you are not registered...
| Subscribe to Krixos Health: | |
|
or call us on: +43 (0)1 27 63 015 or email: subscribe@krixos.com |
|
Most viewed
- 1. Heavy metal burden in the urine and cancer risk
- 2. Suppressing tumour cell stemness might help colon cancer management
- 3. Cholesterol-lowering drugs show promise against colorectal cancer
- 4. Case Report: A case of interstitial pneumonia in a colorectal cancer patient with a history of lung cancer treated with cetuximab
- 5. Prognostic significance of the pretreatment pan-immune-inflammation value in colorectal cancer patients: an updated meta-analysis
- 6. The bidirectional regulatory network between ATF4 and lncRNAs in systemic diseases
- 7. Global research landscape of antiangiogenic therapy for colorectal cancer: a bibliometric analysis of mechanistic insights and clinical advancements
- 8. Predictive model based on blood cell analysis and coagulation function indicators for neuroblastic tumors staging diagnosis
- 9. Genetic variants and clinical determinants affecting the response to 5-Fluorouracil-based treatment in Chilean patients with advanced colorectal cancer
- 10. First subject dosed in Phase I trial of Vir Biotechnology's VIR-5525
Last updated at 6:12 GMT
Hot News Makers
Health/Pharma Companies
-
3585.48
-
885.93
-
862.64
-
510.61
-
441.75
-
398.72
-
389.53
-
387.66
-
352.71
-
309.84
Drugs, Treatments, Trials
-
1321.57
-
736.93
-
474.89
-
296.80
-
179.38
-
163.76
-
163.76
-
136.48
-
133.06
-
127.37
Last updated at 5:10 GMT
